Global Arthritis Drug Market Research Report 2021

SKU ID :QYR-17222067 | Published Date: 20-Jan-2021 | No. of pages: 94
1 Arthritis Drug Market Overview 1.1 Product Overview and Scope of Arthritis Drug 1.2 Arthritis Drug Segment by Type 1.2.1 Global Arthritis Drug Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Synthetic DMARDs 1.2.3 Biological DMARDs 1.2.4 NSAIDs 1.2.5 Corticosteroids 1.2.6 Analgesics 1.3 Arthritis Drug Segment by Application 1.3.1 Arthritis Drug Sales Comparison by Application: (2021-2027) 1.3.2 Retail Pharmacies 1.3.3 Hospital Pharmacies 1.3.4 Drug Stores 1.3.5 E-Commerce 1.4 Global Arthritis Drug Market Size Estimates and Forecasts 1.4.1 Global Arthritis Drug Revenue 2016-2027 1.4.2 Global Arthritis Drug Sales 2016-2027 1.4.3 Arthritis Drug Market Size by Region: 2016 Versus 2021 Versus 2027 2 Arthritis Drug Market Competition by Manufacturers 2.1 Global Arthritis Drug Sales Market Share by Manufacturers (2016-2021) 2.2 Global Arthritis Drug Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Arthritis Drug Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Arthritis Drug Manufacturing Sites, Area Served, Product Type 2.5 Arthritis Drug Market Competitive Situation and Trends 2.5.1 Arthritis Drug Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Arthritis Drug Players Market Share by Revenue 2.5.3 Global Arthritis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Arthritis Drug Retrospective Market Scenario by Region 3.1 Global Arthritis Drug Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Arthritis Drug Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Arthritis Drug Market Facts & Figures by Country 3.3.1 North America Arthritis Drug Sales by Country 3.3.2 North America Arthritis Drug Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Arthritis Drug Market Facts & Figures by Country 3.4.1 Europe Arthritis Drug Sales by Country 3.4.2 Europe Arthritis Drug Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Arthritis Drug Market Facts & Figures by Region 3.5.1 Asia Pacific Arthritis Drug Sales by Region 3.5.2 Asia Pacific Arthritis Drug Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Arthritis Drug Market Facts & Figures by Country 3.6.1 Latin America Arthritis Drug Sales by Country 3.6.2 Latin America Arthritis Drug Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Arthritis Drug Market Facts & Figures by Country 3.7.1 Middle East and Africa Arthritis Drug Sales by Country 3.7.2 Middle East and Africa Arthritis Drug Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Arthritis Drug Historic Market Analysis by Type 4.1 Global Arthritis Drug Sales Market Share by Type (2016-2021) 4.2 Global Arthritis Drug Revenue Market Share by Type (2016-2021) 4.3 Global Arthritis Drug Price by Type (2016-2021) 5 Global Arthritis Drug Historic Market Analysis by Application 5.1 Global Arthritis Drug Sales Market Share by Application (2016-2021) 5.2 Global Arthritis Drug Revenue Market Share by Application (2016-2021) 5.3 Global Arthritis Drug Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Novartis 6.1.1 Novartis Corporation Information 6.1.2 Novartis Description and Business Overview 6.1.3 Novartis Arthritis Drug Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Novartis Product Portfolio 6.1.5 Novartis Recent Developments/Updates 6.2 Eli Lilly 6.2.1 Eli Lilly Corporation Information 6.2.2 Eli Lilly Description and Business Overview 6.2.3 Eli Lilly Arthritis Drug Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Eli Lilly Product Portfolio 6.2.5 Eli Lilly Recent Developments/Updates 6.3 Celltrion 6.3.1 Celltrion Corporation Information 6.3.2 Celltrion Description and Business Overview 6.3.3 Celltrion Arthritis Drug Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Celltrion Product Portfolio 6.3.5 Celltrion Recent Developments/Updates 6.4 F. Hoffmann-La Roche 6.4.1 F. Hoffmann-La Roche Corporation Information 6.4.2 F. Hoffmann-La Roche Description and Business Overview 6.4.3 F. Hoffmann-La Roche Arthritis Drug Sales, Revenue and Gross Margin (2016-2021) 6.4.4 F. Hoffmann-La Roche Product Portfolio 6.4.5 F. Hoffmann-La Roche Recent Developments/Updates 6.5 Pfizer 6.5.1 Pfizer Corporation Information 6.5.2 Pfizer Description and Business Overview 6.5.3 Pfizer Arthritis Drug Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Pfizer Product Portfolio 6.5.5 Pfizer Recent Developments/Updates 6.6 Johnson & Johnson 6.6.1 Johnson & Johnson Corporation Information 6.6.2 Johnson & Johnson Description and Business Overview 6.6.3 Johnson & Johnson Arthritis Drug Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Johnson & Johnson Product Portfolio 6.6.5 Johnson & Johnson Recent Developments/Updates 6.7 GSK 6.6.1 GSK Corporation Information 6.6.2 GSK Description and Business Overview 6.6.3 GSK Arthritis Drug Sales, Revenue and Gross Margin (2016-2021) 6.4.4 GSK Product Portfolio 6.7.5 GSK Recent Developments/Updates 7 Arthritis Drug Manufacturing Cost Analysis 7.1 Arthritis Drug Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Arthritis Drug 7.4 Arthritis Drug Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Arthritis Drug Distributors List 8.3 Arthritis Drug Customers 9 Arthritis Drug Market Dynamics 9.1 Arthritis Drug Industry Trends 9.2 Arthritis Drug Growth Drivers 9.3 Arthritis Drug Market Challenges 9.4 Arthritis Drug Market Restraints 10 Global Market Forecast 10.1 Arthritis Drug Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Arthritis Drug by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Arthritis Drug by Type (2022-2027) 10.2 Arthritis Drug Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Arthritis Drug by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Arthritis Drug by Application (2022-2027) 10.3 Arthritis Drug Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Arthritis Drug by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Arthritis Drug by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer
List of Tables Table 1. Global Arthritis Drug Sales (K Pcs) Growth Rate Comparison by Type (2021-2027) Table 2. Global Arthritis Drug Sales (K Pcs) Comparison by Application (2021-2027) Table 3. Global Arthritis Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Arthritis Drug Covered in This Study Table 5. Global Arthritis Drug Sales (K Pcs) of Key Manufacturers (2016-2021) Table 6. Global Arthritis Drug Sales Share by Manufacturers (2016-2021) Table 7. Global Arthritis Drug Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Arthritis Drug Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Arthritis Drug Average Price (USD/Pcs) of Key Manufacturers (2016-2021) Table 10. Manufacturers Arthritis Drug Manufacturing Sites and Area Served Table 11. Manufacturers Arthritis Drug Product Type Table 12. Global Arthritis Drug Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Arthritis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Arthritis Drug as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Arthritis Drug Sales by Region (2016-2021) & (K Pcs) Table 16. Global Arthritis Drug Sales Market Share by Region (2016-2021) Table 17. Global Arthritis Drug Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Arthritis Drug Sales by Country (2016-2021) & (K Pcs) Table 19. North America Arthritis Drug Sales Market Share by Country (2016-2021) Table 20. North America Arthritis Drug Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Arthritis Drug Revenue Market Share by Country (2016-2021) Table 22. Europe Arthritis Drug Sales by Country (2016-2021) & (K Pcs) Table 23. Europe Arthritis Drug Sales Market Share by Country (2016-2021) Table 24. Europe Arthritis Drug Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Arthritis Drug Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Arthritis Drug Sales by Region (2016-2021) & (K Pcs) Table 27. Asia Pacific Arthritis Drug Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Arthritis Drug Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Arthritis Drug Revenue Market Share by Region (2016-2021) Table 30. Latin America Arthritis Drug Sales by Country (2016-2021) & (K Pcs) Table 31. Latin America Arthritis Drug Sales Market Share by Country (2016-2021) Table 32. Latin America Arthritis Drug Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Arthritis Drug Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Arthritis Drug Sales by Country (2016-2021) & (K Pcs) Table 35. Middle East and Africa Arthritis Drug Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Arthritis Drug Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Arthritis Drug Revenue Market Share by Country (2016-2021) Table 38. Global Arthritis Drug Sales (K Pcs) by Type (2016-2021) Table 39. Global Arthritis Drug Sales Market Share by Type (2016-2021) Table 40. Global Arthritis Drug Revenue (Million US$) by Type (2016-2021) Table 41. Global Arthritis Drug Revenue Share by Type (2016-2021) Table 42. Global Arthritis Drug Price (USD/Pcs) by Type (2016-2021) Table 43. Global Arthritis Drug Sales (K Pcs) by Application (2016-2021) Table 44. Global Arthritis Drug Sales Market Share by Application (2016-2021) Table 45. Global Arthritis Drug Revenue (Million US$) by Application (2016-2021) Table 46. Global Arthritis Drug Revenue Share by Application (2016-2021) Table 47. Global Arthritis Drug Price (USD/Pcs) by Application (2016-2021) Table 48. Novartis Corporation Information Table 49. Novartis Description and Business Overview Table 50. Novartis Arthritis Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 51. Novartis Arthritis Drug Product Table 52. Novartis Recent Developments/Updates Table 53. Eli Lilly Corporation Information Table 54. Eli Lilly Description and Business Overview Table 55. Eli Lilly Arthritis Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 56. Eli Lilly Arthritis Drug Product Table 57. Eli Lilly Recent Developments/Updates Table 58. Celltrion Corporation Information Table 59. Celltrion Description and Business Overview Table 60. Celltrion Arthritis Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 61. Celltrion Arthritis Drug Product Table 62. Celltrion Recent Developments/Updates Table 63. F. Hoffmann-La Roche Corporation Information Table 64. F. Hoffmann-La Roche Description and Business Overview Table 65. F. Hoffmann-La Roche Arthritis Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 66. F. Hoffmann-La Roche Arthritis Drug Product Table 67. F. Hoffmann-La Roche Recent Developments/Updates Table 68. Pfizer Corporation Information Table 69. Pfizer Description and Business Overview Table 70. Pfizer Arthritis Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 71. Pfizer Arthritis Drug Product Table 72. Pfizer Recent Developments/Updates Table 73. Johnson & Johnson Corporation Information Table 74. Johnson & Johnson Description and Business Overview Table 75. Johnson & Johnson Arthritis Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 76. Johnson & Johnson Arthritis Drug Product Table 77. Johnson & Johnson Recent Developments/Updates Table 78. GSK Corporation Information Table 79. GSK Description and Business Overview Table 80. GSK Arthritis Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 81. GSK Arthritis Drug Product Table 82. GSK Recent Developments/Updates Table 83. Production Base and Market Concentration Rate of Raw Material Table 84. Key Suppliers of Raw Materials Table 85. Arthritis Drug Distributors List Table 86. Arthritis Drug Customers List Table 87. Arthritis Drug Market Trends Table 88. Arthritis Drug Growth Drivers Table 89. Arthritis Drug Market Restraints Table 90. Global Arthritis Drug Sales Forecast by Type (2022-2027) & (K Pcs) Table 91. Global Arthritis Drug Sales Market Share Forecast by Type (2022-2027) Table 92. Global Arthritis Drug Revenue Forecast by Type (2022-2027) & (US$ Million) Table 93. Global Arthritis Drug Revenue Market Share Forecast by Type (2022-2027) Table 94. Global Arthritis Drug Sales Forecast by Application (2022-2027) & (K Pcs) Table 95. Global Arthritis Drug Sales Market Share Forecast by Application (2022-2027) Table 96. Global Arthritis Drug Revenue Forecast by Application (2022-2027) & (US$ Million) Table 97. Global Arthritis Drug Revenue Market Share Forecast by Application (2022-2027) Table 98. Global Arthritis Drug Sales Forecast by Region (2022-2027) & (K Pcs) Table 99. Global Arthritis Drug Sales Market Share Forecast by Region (2022-2027) Table 100. Global Arthritis Drug Revenue Forecast by Region (2022-2027) & (US$ Million) Table 101. Global Arthritis Drug Revenue Market Share Forecast by Region (2022-2027) Table 102. Research Programs/Design for This Report Table 103. Key Data Information from Secondary Sources Table 104. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Arthritis Drug Figure 2. Global Arthritis Drug Market Share by Type in 2020 & 2027 Figure 3. Synthetic DMARDs Product Picture Figure 4. Biological DMARDs Product Picture Figure 5. NSAIDs Product Picture Figure 6. Corticosteroids Product Picture Figure 7. Analgesics Product Picture Figure 8. Global Arthritis Drug Market Share by Application in 2020 & 2027 Figure 9. Retail Pharmacies Figure 10. Hospital Pharmacies Figure 11. Drug Stores Figure 12. E-Commerce Figure 13. Global Arthritis Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Arthritis Drug Market Size 2016-2027 (US$ Million) Figure 15. Global Arthritis Drug Sales 2016-2027 (K Pcs) Figure 16. Global Arthritis Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 17. Arthritis Drug Sales Share by Manufacturers in 2020 Figure 18. Global Arthritis Drug Revenue Share by Manufacturers in 2020 Figure 19. The Global 5 and 10 Largest Arthritis Drug Players: Market Share by Revenue in 2020 Figure 20. Arthritis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 21. Global Arthritis Drug Sales Market Share by Region (2016-2021) Figure 22. Global Arthritis Drug Sales Market Share by Region in 2020 Figure 23. Global Arthritis Drug Revenue Market Share by Region (2016-2021) Figure 24. Global Arthritis Drug Revenue Market Share by Region in 2020 Figure 25. U.S. Arthritis Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Canada Arthritis Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Germany Arthritis Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. France Arthritis Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. U.K. Arthritis Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Italy Arthritis Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Russia Arthritis Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. China Arthritis Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Japan Arthritis Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. South Korea Arthritis Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. India Arthritis Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Australia Arthritis Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Taiwan Arthritis Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Indonesia Arthritis Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Thailand Arthritis Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Malaysia Arthritis Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Philippines Arthritis Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Vietnam Arthritis Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Mexico Arthritis Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Brazil Arthritis Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Argentina Arthritis Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Turkey Arthritis Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Saudi Arabia Arthritis Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. U.A.E Arthritis Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. Sales Market Share of Arthritis Drug by Type (2016-2021) Figure 50. Sales Market Share of Arthritis Drug by Application (2016-2021) Figure 51. Sales Market Share of Arthritis Drug by Application in 2020 Figure 52. Revenue Share of Arthritis Drug by Application (2016-2021) Figure 53. Revenue Share of Arthritis Drug by Application in 2020 Figure 54. Manufacturing Cost Structure of Arthritis Drug Figure 55. Manufacturing Process Analysis of Arthritis Drug Figure 56. Arthritis Drug Industrial Chain Analysis Figure 57. Channels of Distribution Figure 58. Distributors Profiles Figure 59. Bottom-up and Top-down Approaches for This Report Figure 60. Data Triangulation Figure 61. Key Executives Interviewed
Novartis Eli Lilly Celltrion F. Hoffmann-La Roche Pfizer Johnson & Johnson GSK
  • PRICE
  • $2900
    $5800
    $4350
    Buy Now

Our Clients